The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAptitude Regulatory News (APTD)

Share Price Information for Aptitude (APTD)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 338.00
Bid: 337.00
Ask: 343.00
Change: 0.00 (0.00%)
Spread: 6.00 (1.78%)
Open: 338.00
High: 0.00
Low: 0.00
Prev. Close: 338.00
APTD Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

22 Apr 2009 07:00

RNS Number : 9366Q
Microgen PLC
22 April 2009
 



microgen

www.microgen.com

22 April 2009

MICROGEN plc

INTERIM MANAGEMENT STATEMENT

Microgen plc ('Microgen' or 'the Group'announces its Interim Management Statement covering the period from 1 January 2009 to the date of this announcement. Microgen announced its final results for the year ending 31 December 2008 on 24 February 2009.

The Group's financial results for the three months ended 31 March 2009 are in line with the Board's expectations. There have been no significant changes in the trading or financial position of Microgen and its balance sheet remains strong. Microgen closed the quarter with £16.3 million of cash (31 December 2008: £14.7 million) and net funds of £13.8 million (31 December 2008: £11.0 million), after the repayment of £1.2 million of the mortgage on the freehold property.

Although markets remain unpredictable, Microgen has had a good start to the yearDuring the first quarter, Microgen Aptitude Solutions Division ('MASD'has won a major new European customer for Microgen Accounting Hub and Microgen Aptitude, against market leading competitors. This significant win, together with a strong prospect bank, should underpin the performance of MASD and support the division's growth projections for 2009. As anticipated, the Billing Services and Financial Systems Divisions have experienced some effects of the depressed economic climate, but the high levels of recurring revenue and strong profitability of these businesses provide high resilience to the economic instability. 

Overall, despite the ongoing difficult market environment, the Group is on track. The Board remains cautiously positive about the outlook for the year and the balance sheet and cash flow remain strong.

Contacts

Martyn Ratcliffe, Chairman

01252-772300

David Sherriff, Chief Operating Officer

Philip Wood, Group Finance Director

Giles Sanderson, Financial Dynamics

Haya Chelhot, Financial Dynamics

020-7831-3113

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
IMSIBMATMMITBAL
Date   Source Headline
20th May 20244:38 pmRNSNotification of Major Holdings
20th May 20247:00 amRNSTransaction in Own Shares
17th May 20247:00 amRNSTransaction in Own Shares
15th May 20247:00 amRNSTransaction in Own Shares
14th May 202410:48 amRNSResult of AGM
14th May 20247:00 amRNSAGM Statement
10th May 20247:00 amRNSTransaction in Own Shares
8th May 20247:00 amRNSNotification of Major Holdings
8th May 20247:00 amRNSTransaction in Own Shares
7th May 20247:00 amRNSTransaction in Own Shares
3rd May 20247:00 amRNSTransaction in Own Shares
1st May 20244:10 pmRNSTotal Voting Rights
30th Apr 20244:46 pmRNSGrant of awards under 2020 Deferred Bonus Plan
29th Apr 20247:00 amRNSTransaction in Own Shares
24th Apr 20247:00 amRNSTransaction in Own Shares
19th Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTransaction in Own Shares
11th Apr 20247:00 amRNSTransaction in Own Shares
10th Apr 20247:00 amRNSTransaction in Own Shares
9th Apr 20247:00 amRNSNotice of 2024 Annual General Meeting
8th Apr 20247:00 amRNSTransaction in Own Shares
4th Apr 20247:00 amRNSTransaction in Own Shares
3rd Apr 20247:00 amRNSTransaction in Own Shares
2nd Apr 20241:46 pmRNSTotal Voting Rights
2nd Apr 20247:00 amRNSTransaction in Own Shares
28th Mar 20247:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
28th Mar 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
26th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
22nd Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:01 amRNSAptitude to Accelerate Autonomous Finance
21st Mar 20247:01 amRNSShare buyback programme
21st Mar 20247:00 amRNSAudited Results for Year Ended 31 December 2023
21st Feb 20247:00 amRNSChange of Broker Arrangements
9th Feb 20247:00 amRNSHolding(s) in Company
31st Jan 20247:00 amRNSHolding(s) in Company
22nd Jan 20247:00 amRNSFull Year Trading Update and Notice of Results
4th Jan 20247:00 amRNSFynapse Win
30th Nov 20237:00 amRNSAppointment of Chief Executive Officer
12th Oct 20237:00 amRNSHolding(s) in Company
2nd Oct 20232:17 pmRNSGrant of awards
29th Sep 20237:00 amRNSBLOCK LISTING SIX MONTHLY RETURN
21st Sep 20232:28 pmRNSHolding(s) in Company
20th Sep 20239:32 amRNSHolding(s) in Company
7th Sep 202310:15 amRNSGrant of Awards under Performance Share Plan
23rd Aug 20231:21 pmRNSHolding(s) in Company
23rd Aug 20231:15 pmRNSHolding(s) in Company
28th Jul 202312:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.